DR. BRENDA A. BURROUGH MD NPI 1326163098

NPI Details

DR. Brenda A. Burrough, MD is a hospitalist in Ames, IA with 22 years of experience. The provider is hospitalists are physicians whose primary professional focus is the general medical care of hospitalized patients. Their activities include patient care, teaching, research, and leadership related to Hospital Medicine. The term 'hospitalist' refers to physicians whose practice emphasizes providing care for hospitalized patients. DR. Brenda A. Burrough, MD NPI is 1326163098. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Graduation Year:2004

The provider's business location address is:

1111 DUFF AVE
AMES, IA
ZIP 50010-745
Phone: (515) 239-6992

The NPI 1326163098 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Hemoglobin a1c level (HCPCS:83036)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Urine microalbumin (protein) level (HCPCS:82043)
• Bacterial colony count, urine (HCPCS:87086)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood test, clotting time (HCPCS:85610)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Automated urinalysis test (HCPCS:81003)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Blood creatinine level (HCPCS:82565)
• Bacterial culture, any other source except urine, blood or stool, aerobic (HCPCS:87070)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Follow-up observation care per day, typically 25 minutes (HCPCS:99225)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Hepatitis c antibody measurement (HCPCS:86803)
• Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report (HCPCS:G0403)
• Hospital observation care on day of discharge (HCPCS:99217)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Protein measurement, serum (HCPCS:84165)
• Special gram or giemsa stain for microorganism (HCPCS:87205)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Removal of impacted ear wax (HCPCS:69210)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Uric acid level, blood (HCPCS:84550)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)

The enumeration date for this NPI number is 3/20/2007 and was last updated on 5/13/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.